智通财经APP讯,精优药业(00858)公布,于2026年10月21日,该公司向3名董事(即谢毅博士、王秀娟女士及及吴祥云先生)及1名服务提供者(毛裕民博士)授出购股权,购股权将赋予承授人权利认购公司股本中合共9200万股每股面值0.01港元的普通股,购股权的行使价为每股0.0726港元。
智通财经APP讯,精优药业(00858)公布,于2026年10月21日,该公司向3名董事(即谢毅博士、王秀娟女士及及吴祥云先生)及1名服务提供者(毛裕民博士)授出购股权,购股权将赋予承授人权利认购公司股本中合共9200万股每股面值0.01港元的普通股,购股权的行使价为每股0.0726港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.